Millennium Management’s BioVie BIVI Stock Holding History

Millennium Management’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,000	Closed	-$756K	–	6188
2023 Q4	$756K	Hold	6,000	–	–	﹤0.01%	4368
2023 Q3	$2.05M	Buy	+6,000	New	+$2.35M	﹤0.01%	3526

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management's BIVI Position: Q1 2025 in Review

Millennium Management sold out of BioVie (BIVI) in Q1 2025, closing a stake of 12,262 shares — an estimated $245K sold.

Millennium Management first reported a position in BIVI in Q4 2020 and held it in 9 quarters. The position peaked at $1.44M in Q2 2023. 37 funds tracked by Wall St. Rank hold BIVI as of Q1 2025.

Millennium Management reported no remaining BioVie position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 12,262 BioVie shares in Q1 2025, an estimated $245K.
Millennium Management first reported a position in BioVie in Q4 2020 and held it in 9 quarters.
Millennium Management's BioVie position peaked at $1.44M in Q2 2023.
37 funds tracked by Wall St. Rank held BioVie as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.